Home/Pipeline/Felix NeuroAI™ Wristband

Felix NeuroAI™ Wristband

Essential Tremor

ApprovedActive

Key Facts

Indication

Essential Tremor

Phase

Approved

Status

Active

Company

Fasikl

About Fasikl

Fasikl is a private, clinical-stage biotech company developing AI-driven neuromodulation therapies. The company has achieved a significant milestone with the FDA clearance of its first product, Felix, for essential tremor, validating its core neuro-AI platform. Built on over two decades of foundational R&D, Fasikl's technology includes advanced neural interfaces and AI models capable of single-fiber resolution recording and stimulation. The company is positioned to expand its platform into a broad pipeline of neurological indications and next-generation nerve-computer interfaces.

View full company profile

Therapeutic Areas

Neurology Movement Disorders

Other Essential Tremor Drugs

Drug	Company	Phase	Status
SAGE-324	Sage Therapeutics	Phase 2	Active
Platform Expansion	Rune Labs	Research	Active
Exablate Neuro	Insightec	Approved	Active
GABA-A PAM for Essential Tremor	Modulate Bio	Preclinical	Active
Ulixacaltamide (PRAX-944)	Praxis Precision Medicines	Phase 3	Active